Twenty-First Century Precision Medicine in Oncology: Genomic Profiling in Patients With Cancer

Mitesh J Borad, Patricia M. LoRusso

Research output: Contribution to journalReview article

7 Citations (Scopus)

Abstract

The advent of next-generation sequencing has accelerated the implementation of genomic profiling in the care and management of patients with cancer. Initial efforts have focused on target identification in patients with advanced cancer. Prognostication, resistance detection, disease monitoring, and early detection efforts are also underway. This review highlights some of the challenges in this evolving space. This includes choosing between gene-panel and comprehensive approaches, DNA and transcriptome data integration, reduction of false-positive variants, addressing tumor heterogeneity, establishment of workflows to address unsolicited findings, and data sharing and privacy concerns.

Original languageEnglish (US)
Pages (from-to)1583-1591
Number of pages9
JournalMayo Clinic Proceedings
Volume92
Issue number10
DOIs
StatePublished - Oct 1 2017

Fingerprint

Precision Medicine
Early Diagnosis
Patient Care Management
Neoplasms
Workflow
Information Dissemination
Privacy
Transcriptome
DNA
Genes

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Twenty-First Century Precision Medicine in Oncology : Genomic Profiling in Patients With Cancer. / Borad, Mitesh J; LoRusso, Patricia M.

In: Mayo Clinic Proceedings, Vol. 92, No. 10, 01.10.2017, p. 1583-1591.

Research output: Contribution to journalReview article

@article{8bc6988c173145b3846ea24ae9bd6bbd,
title = "Twenty-First Century Precision Medicine in Oncology: Genomic Profiling in Patients With Cancer",
abstract = "The advent of next-generation sequencing has accelerated the implementation of genomic profiling in the care and management of patients with cancer. Initial efforts have focused on target identification in patients with advanced cancer. Prognostication, resistance detection, disease monitoring, and early detection efforts are also underway. This review highlights some of the challenges in this evolving space. This includes choosing between gene-panel and comprehensive approaches, DNA and transcriptome data integration, reduction of false-positive variants, addressing tumor heterogeneity, establishment of workflows to address unsolicited findings, and data sharing and privacy concerns.",
author = "Borad, {Mitesh J} and LoRusso, {Patricia M.}",
year = "2017",
month = "10",
day = "1",
doi = "10.1016/j.mayocp.2017.08.002",
language = "English (US)",
volume = "92",
pages = "1583--1591",
journal = "Mayo Clinic Proceedings",
issn = "0025-6196",
publisher = "Elsevier Science",
number = "10",

}

TY - JOUR

T1 - Twenty-First Century Precision Medicine in Oncology

T2 - Genomic Profiling in Patients With Cancer

AU - Borad, Mitesh J

AU - LoRusso, Patricia M.

PY - 2017/10/1

Y1 - 2017/10/1

N2 - The advent of next-generation sequencing has accelerated the implementation of genomic profiling in the care and management of patients with cancer. Initial efforts have focused on target identification in patients with advanced cancer. Prognostication, resistance detection, disease monitoring, and early detection efforts are also underway. This review highlights some of the challenges in this evolving space. This includes choosing between gene-panel and comprehensive approaches, DNA and transcriptome data integration, reduction of false-positive variants, addressing tumor heterogeneity, establishment of workflows to address unsolicited findings, and data sharing and privacy concerns.

AB - The advent of next-generation sequencing has accelerated the implementation of genomic profiling in the care and management of patients with cancer. Initial efforts have focused on target identification in patients with advanced cancer. Prognostication, resistance detection, disease monitoring, and early detection efforts are also underway. This review highlights some of the challenges in this evolving space. This includes choosing between gene-panel and comprehensive approaches, DNA and transcriptome data integration, reduction of false-positive variants, addressing tumor heterogeneity, establishment of workflows to address unsolicited findings, and data sharing and privacy concerns.

UR - http://www.scopus.com/inward/record.url?scp=85030457091&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85030457091&partnerID=8YFLogxK

U2 - 10.1016/j.mayocp.2017.08.002

DO - 10.1016/j.mayocp.2017.08.002

M3 - Review article

C2 - 28982488

AN - SCOPUS:85030457091

VL - 92

SP - 1583

EP - 1591

JO - Mayo Clinic Proceedings

JF - Mayo Clinic Proceedings

SN - 0025-6196

IS - 10

ER -